Background
When a patient suffers an acute ischaemic stroke (AIS), thrombolysis with tissue plasminogen activator (tPA), intravenous alteplase, will be given as soon as possible, if appropriate.1–3 Patients mostly receive tPA within 4.5 hours after the onset of symptoms and with an in-hospital door-to-needle time (DNT) of 60 min or less.1
For patients with AIS, a median DNT of 20 min is feasible when neurologists organise the diagnostic pathway in a tertiary hospital.4 However, even recently concerns have been raised as to why in most hospitals the implementation of an evidence-based stroke protocol has not been successful.5
In Finland, emergency medicine was recognised as one of the medical specialties in 2013.6 Shortly thereafter, the chief neurologist of our hospital, Kanta-Häme Central Hospital (K-HCH), proposed a reorganisation of the AIS process. K-HCH is a tertiary hospital situated 80 km from Tampere University Hospital. K-HCH serves as a primary stroke centre for patients presenting with acute stroke symptoms.
We implemented a new treatment protocol for patients who had a stroke in our emergency department (ED), mainly led by emergency physicians (EPs).7 CT, CT angiography and CT perfusion are used for stroke imaging. Availability of MRI is limited mainly to office hours imaging if needed. Thrombolysis is delivered in the CT room. Prior to thrombolysis, the patient’s background, symptoms and their temporal relationship to the onset of stroke are considered. Additionally, the National Institutes of Health Stroke Scale (NIHSS) score and any contraindications to thrombolysis are evaluated. Furthermore, any potential delay in the immediate radiologist’s report is noted, as is the time stamp for door-in-door out for patients who require thrombectomy. All data, including DNT, were collected in conjunction with manual thrombolysis forms and electronic patient records.
We were able to show that it is possible to achieve a median DNT of 20 min with clinical results at least comparable to those in a system led by experienced neurologists.8 Other studies on AIS protocols have reported findings similar to ours.9–11
In quality research, the outcome of time-dependent variables can be evaluated by calculating not only means or medians but also the upper and lower control limits (UCL and LCL) of the process.12 Statistical process control (SPC) charts are used in a wide variety of processes.13–15 SPC charts are also known as Shewhart charts according to their inventor, Walter Shewhart, who was working for Bell Labs in the 1920s. Charts can be used as a SPC tool to monitor whether a manufacturing or business process is in a state of control. Thus, the variation and its divergences are presented in visible form for a single employee. Using SPC charts, the process can be systematically analysed and, if necessary, deviations can be addressed to correct the process, thereby improving the quality of the process.
Although AIS patients can be treated safely and without delay, it is not certain whether the quality of the process remains constant.16 The aim of the present study is to assess retrospectively whether interpreting SPC charts could be useful in identifying possible DNT deviations in the AIS treatment process in the ED.